HDIM
AVNS icon

Hanson & Doremus Investment Management’s Avanos Medical AVNS Stock Holding History

Hanson & Doremus Investment Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-39
Closed -$1K – 444
2016
Q2 		$1K Hold
39
– – ﹤0.01% 431
2016
Q1 		$1K Hold
39
– – ﹤0.01% 448
2015
Q4 		$1K Sell
39
-77
-66% -$2.39K ﹤0.01% 458
2015
Q3 		$3K Hold
116
– – ﹤0.01% 417
2015
Q2 		$5K Hold
116
– – ﹤0.01% 408
2015
Q1 		$6K Sell
116
-25
-18% -$1.16K ﹤0.01% 406
2014
Q4 		$6K Buy
+141
New +$5.54K ﹤0.01% 406

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Hanson & Doremus Investment Management's AVNS Position: Q3 2016 in Review

Hanson & Doremus Investment Management sold out of Avanos Medical (AVNS) in Q3 2016, closing a stake of 39 shares — an estimated $1K sold.

Hanson & Doremus Investment Management first reported a position in AVNS in Q4 2014 and held it in 7 quarters. The position peaked at $6K in Q1 2015. 358 funds tracked by Wall St. Rank hold AVNS as of Q3 2016.

  • Hanson & Doremus Investment Management reported no remaining Avanos Medical position as of Q3 2016 after selling out during the quarter.
  • Hanson & Doremus Investment Management sold 39 Avanos Medical shares in Q3 2016, an estimated $1K.
  • Hanson & Doremus Investment Management first reported a position in Avanos Medical in Q4 2014 and held it in 7 quarters.
  • Hanson & Doremus Investment Management's Avanos Medical position peaked at $6K in Q1 2015.
  • 358 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2016.

Based on Hanson & Doremus Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.